Exelixis off label promotion-they know how to do it and get away with it

Discussion in 'Pharma/Biotech Comp - Gen Discussion |Pharma Sales' started by anonymous, Dec 27, 2017 at 5:43 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Now that Exelixis received FDA approval for HCC, they won't need to do any more off label promotion in liver cancer. They can focus their efforts in promoting off label for many other disease states. They do such a good job in off label promotion. In a very small company that only has one drug, but a large external sales force and very large MSL team, it is the only way to keep driving their stock price up.
     

  2. anonymous

    anonymous Guest

    Thanks fired MSL from the east. Too bad you can’t read. Exelixis did not get an approval for HCC, nor is there any reason for off label promotion. You’re still crazy...we’ll give you that!
     
  3. anonymous

    anonymous Guest

    Crumbling
     
  4. anonymous

    anonymous Guest

    No Puma